Synmosa Biopharma Corporation announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced total revenue was TWD 778.151 million compared to TWD 685.965 million a year ago. Operating income was TWD 33.451 million compared to operating loss of TWD 27.540 million a year ago. Net income was TWD 76.042 million compared to TWD 417.765 million a year ago. Basic earnings per share from continuing operations was TWD 0.29 compared to TWD 1.66 a year ago. Diluted earnings per share from continuing operations was TWD 0.29 compared to TWD 1.65 a year ago. For the half year, total revenue was TWD 1,538.490 million compared to TWD 1,472.256 million a year ago. Operating income was TWD 71.542 million compared to TWD 14.250 million a year ago. Net income was TWD 136.997 million compared to TWD 482.374 million a year ago. Basic earnings per share from continuing operations was TWD 0.52 compared to TWD 1.92 a year ago. Diluted earnings per share from continuing operations was TWD 0.51 compared to TWD 1.92 a year ago.